Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.
Florida: below-average open trial sites
3,625 of 10,986 in-state trials are recruiting (33%); below the 37% national average by 4 percentage points.
According to ClinicalTrials.gov-derived indexes, Florida sits in the top decile of US states by in-state trial count (#2 of 52 states by registered in-state trial count).
Florida: 10,986 US clinical trials with in-state sites, 3,625 recruiting.
Florida has 10,986 registered US clinical trials with a study site in-state, 3,625 of them currently recruiting (below the 37% national average by 4 percentage points). 2,687 of these trials are in Phase 3 (late-stage) and 2,727 in Phase 2. The most frequently studied condition in Florida is Breast Cancer, with 206 linked trials.
Peer research-density states
Florida is in the top decile by in-state trial count. Nearest hubs by indexed volume (not open-share twins):
- New York (10,554)
- Texas (9,951)
- Massachusetts (7,667)
- Pennsylvania (6,946)
- Illinois (6,854)
Ranked from 51 other states with active in-state trials by how close each state's indexed trial count sits to Florida's.
Below-average open enrollment
Florida still shows 3,625 recruiting of 10,986 in-state trials (33% open), but below the 37% national average by 4 percentage points, so archived statuses weigh heavier than the national baseline.
- 33%
- open (below national share)
- 3,625
- still recruiting despite cool share
- 2,727
- Phase 2 rows in this footprint
- 206
- top: Breast Cancer
Recruiting share is below the 37% national average by 4 percentage points. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.
Florida vs all states by indexed in-state trial count
Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)
10,986 Top 4% more indexed trials than 96% of 52 states
States, banded by indexed in-state trial count
Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov · 2026-08-08
Key findings
What ClinicalTrials.gov does not surface for Florida on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Florida open-enrollment share sits below the national baseline.
3,625 of 10,986 in-state trials (33%) are recruiting, against 37% nationally (-4 percentage points). Counts include every study with at least one recorded site in the state.
-
Florida trial sites spread across 8 city hubs.
Miami lists 3,349 of 10,986 in-state trials (30.5%) across 1,697 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.
-
Breast Cancer is the most-studied condition in Florida.
206 of 10,986 in-state trials (1.9%) list Breast Cancer. That is a local concentration figure, not a national disease ranking.
-
Florida sponsorship is fragmented across many organizations.
University of Florida appears on 407 of 10,986 in-state trials (3.7%). Sponsor identity is as filed on ClinicalTrials.gov.
-
4,999 Florida trials carry a completed status.
4,999 of 10,986 (45.5%) are completed. The open share above is the remainder that still lists recruiting.
By Status
| Status | Trial count |
|---|---|
| Completed | 4,999 |
| Recruiting | 3,625 |
| Active | 2,362 |
By Phase
| Phase | Trial count |
|---|---|
| Phase 2 | 2,727 |
| Phase 3 | 2,687 |
| NA | 1,978 |
| Phase 1 | 1,901 |
| Phase 4 | 431 |
| Early Phase 1 | 40 |
Top Conditions
Top Sponsors
Where trials run in Florida
Miami carries 3,349 of Florida's 10,986 indexed trials (30%) across 1,697 named sites, ahead of Tampa at 2,450. 8 cities clear five listed trials, together naming 5,044 distinct sites.
| City | Trials | Listed sites |
|---|---|---|
| Miami | 3,349 | 1,697 |
| Tampa | 2,450 | 843 |
| Jacksonville | 2,206 | 658 |
| Orlando | 1,738 | 731 |
| Gainesville | 1,430 | 462 |
| St. Petersburg | 499 | 249 |
| Fort Myers | 470 | 214 |
| Sarasota | 456 | 190 |
Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.
Volume high
Florida indexes 10,986 in-state trials (p98 by registry volume among 52 states with sites).
Florida: in-state trial volume sits in the high tercile
Sites spread across 8 cities with five or more listed trials, led by Miami (3,349, 30% of the state total) and Tampa (2,450), together naming 5,044 distinct research locations.
Phase mix: 2,687 Phase 3 vs 2,727 Phase 2 (balanced across stages).
Top condition: Breast Cancer (206 trials); top sponsor University of Florida (407).
high-volume · mid-open figures (10,986 trials · 33% open) describe registry geography under the volume high read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.
States near Florida on in-state trial volume
Cross-state peers under the volume high read (high-volume · mid-open), not the same-state browse list.
Similar high-volume hubs (± open share)
- New York · 10,554 trials · 35% recruiting
- Texas · 9,951 trials · 37% recruiting
- Massachusetts · 7,667 trials · 35% recruiting
- Pennsylvania · 6,946 trials · 34% recruiting
- Illinois · 6,854 trials · 33% recruiting
Similar mid-open peers (± trial volume)
- California · 33% recruiting · 16,646 trials
- New Hampshire · 33% recruiting · 471 trials
- Iowa · 33% recruiting · 1,544 trials
- North Carolina · 33% recruiting · 5,625 trials
- Washington · 33% recruiting · 2,795 trials